Good news all around

Good news came from all three companies on my watch list.

GSK:

• Came up to $44.50 after last friday's low $43.91 closing price.
• FDA grants priority review for GlaxoSmithKline's bleeding disorder drug, you can find the news link at here. (provided by www.reuters.com)

BVN:

• Operations resumes at four sites after last week's strike breakout. You can find out more at PR Newswire and Reuters.com.
  

RIO:

• Brazil based mining company Vale announced their quarterly earning on Feb 29th, its revenue rose 12.2% and its net earning was increased by 59%. (www.fools.com)